other names
{{ Info.Overview }}
Revenue {{ Info.Revenue | formatUSD }}
Headquarters {{ Info.Headquarters }}

Adviser Profile

As of Date 03/28/2024
Adviser Type - Large advisory firm
Number of Employees 13 8.33%
of those in investment advisory functions 5
Registration SEC, Approved, 12/5/2000
AUM* 1,057,000,000 -17.23%
of that, discretionary 1,057,000,000 -17.23%
Private Fund GAV* 1,057,800,000 -17.67%
Avg Account Size 88,083,333 -17.23%
SMA’s No
Private Funds 6
Contact Info 650 xxxxxxx
Websites

Client Types

- Pooled investment vehicles

Advisory Activities

- Portfolio management for pooled investment vehicles

Compensation Arrangments

- A percentage of assets under your management
- Performance-based fees

Reported AUM

Discretionary
Non-discretionary
2B 2B 2B 1B 1B 708M 354M
2015 2016 2017 2018 2019 2020 2021 2022 2023

Private Funds



Employees

Private Funds Structure

Fund Type Count GAV
Fund TypeHedge Fund Count6 GAV$1,057,800,000

Similar advisers

Adviser Hedge Fund Liquidity Fund Private Equity Fund Real Estate Fund Securitized Asset Fund Venture Capital Fund Other Fund Total Private Fund GAV AUM #Funds
Adviser JANA PARTNERS LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV- AUM1.3b #Funds-
Adviser INFRASTRUCTURE CAPITAL ADVISORS, LLC Hedge Fund11.8m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV11.8m AUM1.7b #Funds1
Adviser QUINN OPPORTUNITY PARTNERS Hedge Fund611.6m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV611.6m AUM1.0b #Funds3
Adviser VESTAL POINT CAPITAL, LP Hedge Fund736.3m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV736.3m AUM1.8b #Funds1
Adviser BELSTAR MANAGEMENT COMPANY, LLC Hedge Fund628.6m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV628.6m AUM649.4m #Funds2
Adviser THIRD AVENUE MANAGEMENT LLC Hedge Fund17.9m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV17.9m AUM1.4b #Funds1
Adviser FIRST LIGHT ASSET MANAGEMENT, LLC Hedge Fund759.1m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV759.1m AUM1.4b #Funds3
Adviser COLUMBUS HILL CAPITAL MANAGEMENT, L.P. Hedge Fund1.3b Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV1.3b AUM1.3b #Funds4
Adviser HOLDCO ASSET MANAGEMENT, LP Hedge Fund2.4b Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV2.4b AUM2.4b #Funds6
Adviser COHANZICK MANAGEMENT LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV- AUM880.6m #Funds-

Top Holdings

Stock Ticker Stock Name $ Position % Position $ Change # Change
Stck Ticker457669307 Stock NameINSMED INC $ Position$143,310,521 % Position17.00% $ Change19.00% # Change-52.00%
Stck Ticker09061G101 Stock NameBIOMARIN PHARMACEUTICAL INC $ Position$93,046,649 % Position11.00% $ Change-6.00% # Change0.00%
Stck Ticker03152W109 Stock NameAMICUS THERAPEUTICS INC $ Position$89,576,043 % Position10.00% $ Change-19.00% # Change-3.00%
Stck Ticker91307C102 Stock NameUNITED THERAPEUTICS CORP $ Position$85,025,455 % Position10.00% $ Change38.00% # Change0.00%
Stck Ticker852312305 Stock NameSTAAR SURGICAL CO $ Position$65,778,881 % Position8.00% $ Change25.00% # Change0.00%
Stck Ticker09062X103 Stock NameBIOGEN INC $ Position$67,007,571 % Position8.00% $ Change7.00% # Change0.00%
Stck Ticker004225108 Stock NameACADIA PHARMACEUTICALS INC $ Position$39,306,166 % Position5.00% $ Change-12.00% # Change0.00%
Stck Ticker02043QAB3 Stock NameALNYLAM PHARMACEUTICALS INC $ Position$44,498,889 % Position5.00% $ Change # Change
Stck Ticker803607100 Stock NameSAREPTA THERAPEUTICS INC $ Position$31,865,914 % Position4.00% $ Change22.00% # Change0.00%
Stck TickerG72800108 Stock NamePROTHENA CORP PLC $ Position$34,394,042 % Position4.00% $ Change-17.00% # Change0.00%

Brochure Summary

Overview

PAI is the investment adviser to private pooled investment vehicles, the securities of which are offered to investors on a private placement basis (each a “Fund” and collectively, the “Funds”). Its principals and the leaders of its portfolio team are Dr. A. Joon Yun and Dr. Patrick Lee. PAI was previously Palo Alto Investors, LLC, a California limited liability company. On March 30, 2018, it converted into a California limited partnership. At the same time, it organized its affiliate, PAI LLC, a California limited liability company with which it is under common control, to act as the general partner of the Funds that are organized as limited partnerships, and PAI entered into an Investment Adviser Agreement with each of the Funds pursuant to which it manages their assets. PAI was founded by William L. Edwards. While Drs. Yun and Lee have led portfolio management team for some time, until December 31, 2012, Mr. Edwards was PAI’s chairman, chief executive officer and chief investment officer, and the chairman, chief executive officer and sole shareholder of Palo Alto Investors,
a California corporation that served as its manager. Effective as of January 1, 2013, Mr. Edwards transitioned the management of PAI to Drs. Yun and Lee. In connection with that transition, Drs. Yun and Lee replaced Palo Alto Investors as the co- managers of PAI and Mr. Edwards resigned as the PAI’s chairman, chief executive officer and chief investment officer. As of December 31, 2023, PAI had total discretionary assets under management of approximately $1.06 billion. PAI manages assets only on a discretionary basis. PAI invests principally, but not exclusively, in equity and equity-related securities that are traded publicly in U.S. markets and issued by companies primarily in the healthcare industry. Regardless of its current focus, for each of the Funds, PAI is authorized to enter into any type of investment transaction that it deems appropriate under the terms of each Fund’s partnership or investment agreement. The investors in the Funds have no opportunity to select or evaluate any Fund investments or strategies. PAI selects all Fund investments and strategies.